Yes, gonorrhea can come back after treatment without any new sexual exposure. This happens when the original infection was never fully cleared by antibiotics, a scenario known as treatment failure. It is not the bacteria lying dormant and reactivating on its own like herpes. Instead, a small number of bacteria survive the antibiotic, continue multiplying, and eventually cause noticeable symptoms again or show up on a follow-up test.
Treatment Failure vs. Reinfection
When gonorrhea returns after treatment, there are really only two explanations: either the antibiotics didn’t fully eliminate the bacteria (treatment failure), or you were exposed again through sexual contact with an infected partner (reinfection). Gonorrhea does not hide in your body and spontaneously flare up months later the way some viruses do. The bacterium that causes it, Neisseria gonorrhoeae, needs to be actively growing to persist. So if a test comes back positive weeks after treatment and you haven’t had new exposure, the most likely explanation is that the first round of antibiotics didn’t finish the job.
Distinguishing between these two scenarios can be tricky. Clinicians typically look at the timeline, whether your partner was also treated, and sometimes compare the genetic profile of the bacterial strain from each positive test. If your partner wasn’t treated and you resumed sexual contact, reinfection is the simpler explanation. But if both partners were treated and there’s been no outside contact, treatment failure becomes the leading suspect.
Why Antibiotics Sometimes Don’t Work
The standard treatment for uncomplicated gonorrhea is a single injection of ceftriaxone. For genital and rectal infections, this works extremely well, curing over 99% of cases with currently circulating strains. But “over 99%” is not 100%, and several factors can tip the odds against you.
Antibiotic resistance is the most pressing concern. Between 2022 and 2024, the percentage of gonorrhea strains resistant to ceftriaxone jumped from 0.8% to 5% globally, according to WHO surveillance data. Resistance to cefixime, an oral alternative used in some countries, rose from 1.7% to 11% in the same period. These numbers are still relatively small, but they’re climbing fast. If the strain you’re infected with has even moderately reduced sensitivity to ceftriaxone, the standard single dose may not generate enough antibiotic concentration for long enough to kill every bacterium.
There’s also a subtler issue: bacteria that aren’t technically classified as “resistant” by lab standards can still survive treatment in certain parts of the body. A strain with an elevated but not officially resistant level of tolerance to ceftriaxone might be cleared from the genitals but persist in the throat, where the drug behaves differently.
Throat Infections Are the Biggest Risk
Pharyngeal (throat) gonorrhea is the infection most likely to survive treatment. This is true regardless of which antibiotic is used. The CDC notes that few antibiotic regimens reliably cure more than 90% of throat infections, compared to the 99%+ cure rate for genital gonorrhea. Nearly all reported ceftriaxone treatment failures internationally have occurred at the pharynx.
The reason is pharmacological. Ceftriaxone reaches high concentrations in the blood and genital tissues, but salivary and tonsillar levels don’t mirror what’s in the bloodstream. Nearly 90% of the antibiotic can become protein-bound in tonsillar tissue, meaning it’s essentially locked up and unable to attack the bacteria. The result is that a single standard dose may not maintain a high enough active concentration in the throat long enough to fully eradicate the infection, especially if the strain has even slightly elevated tolerance.
This is why current guidelines recommend that everyone treated for throat gonorrhea return for a follow-up test (called a test of cure) 7 to 14 days after treatment. Genital infections don’t routinely require this step because the cure rate is so high, but for the throat, confirming the infection is actually gone is considered essential.
How You’d Know It Came Back
Most throat gonorrhea infections cause no symptoms at all, which makes follow-up testing even more important. You could feel perfectly fine and still be carrying an active infection that the antibiotics failed to clear. Genital infections are more likely to produce discharge or burning during urination, but even these symptoms can be mild enough to dismiss, especially if you assume you’ve already been cured.
If you were treated and your symptoms return within a few weeks, or if a follow-up test comes back positive despite no new sexual contact, treatment failure is the most straightforward explanation. The bacteria never left. They were reduced to a small enough population that symptoms temporarily improved, but they rebounded once the antibiotic cleared your system.
One testing nuance worth knowing: the most common gonorrhea tests (nucleic acid amplification tests) detect bacterial DNA, not live bacteria. Dead bacterial DNA can linger for a short time after successful treatment. Testing too early, within the first week, can sometimes produce a positive result even though the infection has been cleared. That’s why the recommended window for a test of cure is 7 to 14 days post-treatment, not immediately after.
What Happens After Treatment Failure
If your infection didn’t respond to the first round of treatment, a higher dose or a different antibiotic combination is typically the next step. The specific approach depends on the infection site and, ideally, on susceptibility testing of the bacterial strain. For throat infections in particular, options are limited. Ceftriaxone remains the only antibiotic that reliably works at that site, and alternatives like gentamicin are unlikely to be effective in the pharynx.
There’s an additional consequence of incomplete treatment that extends beyond your own health. When bacteria are exposed to antibiotic concentrations that are too low to kill them, it creates exactly the right conditions for resistance to develop. The surviving bacteria, along with related species naturally present in the throat, can exchange genetic material and develop new resistance mechanisms. In this way, a single treatment failure can contribute to the broader problem of drug-resistant gonorrhea.
Reducing Your Risk of Treatment Failure
You can’t control whether the strain you’re infected with has reduced antibiotic sensitivity, but a few practical steps lower the chances of treatment failure. Make sure your provider knows about all infection sites. If you’ve had oral sex, mention it explicitly so the throat can be tested and treated appropriately. A genital-only treatment plan could leave a pharyngeal infection completely unaddressed.
If you’re prescribed a single injection, there’s no adherence issue to worry about since the dose is given in the clinic. But if any oral antibiotics are part of your regimen, completing the full course matters. Return for a test of cure if your provider recommends one, particularly for throat infections. And ensure your sexual partner is also tested and treated before resuming contact. Reinfection from an untreated partner is actually the most common reason gonorrhea appears to “come back,” even more common than true treatment failure.